FTL LABS CORP — Department of Defense SBIR Phase II: SBIR PHASE II TO FTL LABS CORPORATION, BAA TOPIC DHA251-001

FTL LABS CORP — SBIR Phase II award from Department of Defense.

Phase II SBIR prototype / development signal

  • Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $1,299,885 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.

Informational capture context from public federal data — not legal or bid advice.

Summary

FTL Labs Corp received a $1.3 million SBIR Phase II award from the Defense Health Agency. The funding supports development work on the agency's topic DHA251-001.

Amount
$1,299,885
Agency
Department of Defense · Defense Health Agency
Program / Phase
SBIR · Phase II
NAICS
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place of performance
MA
Period
2026-04-10 → 2028-08-09

Technology domains

Human Performance & Medical

Description

SBIR PHASE II TO FTL LABS CORPORATION, BAA TOPIC DHA251-001

View on USASpending.gov ↗